We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The symptoms and epidemiology of botulism.
Find out about the long-term effects some people can have after having COVID-19.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Employment Appeal Tribunal Judgment of Judge Ford on 3 May 2024.
Information about COVID-19 and pregnancy from the Royal College of Obstretricians and Gynaecologists (RCOG).
Advice for medical professionals to follow when assessing drivers with neurological disorders.
Information on the reporting, investigation and management of acute flaccid paralysis (AFP) and acute flaccid myelitis (AFM).
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
The characteristics, diagnosis, management, surveillance and epidemiology of Shiga toxin-producing Escherichia coli (STEC).
Advice and guidance on the health needs of migrant patients from Ukraine for healthcare practitioners.
How to use a case-control study to evaluate your digital health product.
The review of the safety of isotretinoin has concluded.
Healthcare professionals prescribing montelukast should be alert to the risk of neuropsychiatric reactions in all patients including children and adolescents. Reported neuropsychiatric reactions include sleep disorders, hallucinations, anxiety and depression, as well as changes in behaviour and mood. Healthcare professionals...
Guidance relating to blood clotting, myocarditis and Guillain-Barré Syndrome (GBS) after COVID-19 vaccination.
Guidance on how to license electronic cigarettes and other inhaled nicotine-containing products (NCPs) as medicines in the UK.
How investigators and sponsors should manage clinical trials during COVID-19
Protocols and procedures for testing the value for cultivation or use (VCU) of agricultural crops.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.